These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 21317689)

  • 1. The cost-effectiveness of herpes simplex virus-2 suppressive therapy with daily aciclovir for delaying HIV disease progression among HIV-1-infected women in South Africa.
    Vickerman P; Devine A; Foss AM; Delany-Moretlwe S; Mayaud P; Meyer-Rath G
    Sex Transm Dis; 2011 May; 38(5):401-9. PubMed ID: 21317689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa.
    Delany S; Mlaba N; Clayton T; Akpomiemie G; Capovilla A; Legoff J; Belec L; Stevens W; Rees H; Mayaud P
    AIDS; 2009 Feb; 23(4):461-9. PubMed ID: 19155993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aciclovir treatment for human immunodeficiency virus-1: is the “juice worth the squeeze?”.
    Cohen MS; Eron JJ
    Sex Transm Dis; 2011 May; 38(5):410-2. PubMed ID: 22256341
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-effectiveness of herpes simplex virus type 2 serologic testing and antiviral therapy in pregnancy.
    Baker D; Brown Z; Hollier LM; Wendel GD; Hulme L; Griffiths DA; Mauskopf J
    Am J Obstet Gynecol; 2004 Dec; 191(6):2074-84. PubMed ID: 15592294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of daily aciclovir on HIV disease progression in individuals in Rakai, Uganda, co-infected with HIV-1 and herpes simplex virus type 2: a randomised, double-blind placebo-controlled trial.
    Reynolds SJ; Makumbi F; Newell K; Kiwanuka N; Ssebbowa P; Mondo G; Boaz I; Wawer MJ; Gray RH; Serwadda D; Quinn TC
    Lancet Infect Dis; 2012 Jun; 12(6):441-8. PubMed ID: 22433279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled pilot trial of valacyclovir for attenuating inflammation and immune activation in HIV/herpes simplex virus 2-coinfected adults on suppressive antiretroviral therapy.
    Yi TJ; Walmsley S; Szadkowski L; Raboud J; Rajwans N; Shannon B; Kumar S; Kain KC; Kaul R; Tan DH
    Clin Infect Dis; 2013 Nov; 57(9):1331-8. PubMed ID: 23946220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study.
    Badri M; Cleary S; Maartens G; Pitt J; Bekker LG; Orrell C; Wood R
    Antivir Ther; 2006; 11(1):63-72. PubMed ID: 16518961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial.
    Celum C; Wald A; Hughes J; Sanchez J; Reid S; Delany-Moretlwe S; Cowan F; Casapia M; Ortiz A; Fuchs J; Buchbinder S; Koblin B; Zwerski S; Rose S; Wang J; Corey L;
    Lancet; 2008 Jun; 371(9630):2109-19. PubMed ID: 18572080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. African women recently infected with HIV-1 and HSV-2 have increased risk of acquiring Neisseria gonorrhoeae and Chlamydia trachomatis in the Methods for Improving Reproductive Health in Africa trial.
    Venkatesh KK; van der Straten A; Mayer KH; Blanchard K; Ramjee G; Lurie MN; Chipato T; Padian NS; de Bruyn G
    Sex Transm Dis; 2011 Jun; 38(6):562-70. PubMed ID: 21278624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health care seeking among men with genital ulcer disease in South Africa: correlates and relationship to human immunodeficiency virus-1 and herpes simplex virus type 2 detection and shedding.
    Leichliter JS; Lewis DA; Sternberg M; Habel MA; Paz-Bailey G
    Sex Transm Dis; 2011 Sep; 38(9):865-70. PubMed ID: 21844743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
    Zuckerman RA; Lucchetti A; Whittington WL; Sanchez J; Coombs RW; Zuñiga R; Magaret AS; Wald A; Corey L; Celum C
    J Infect Dis; 2007 Nov; 196(10):1500-8. PubMed ID: 18008230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in healing and reduction in HIV shedding with episodic acyclovir therapy as part of syndromic management among men: a randomized, controlled trial.
    Paz-Bailey G; Sternberg M; Puren AJ; Markowitz LE; Ballard R; Delany S; Hawkes S; Nwanyanwu O; Ryan C; Lewis DA
    J Infect Dis; 2009 Oct; 200(7):1039-49. PubMed ID: 19715417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus-1 infection correlates strongly with herpes simplex virus-2 (genital herpes) seropositivity in South African and United States blood donations.
    Benjamin RJ; Busch MP; Fang CT; Notari EP; Puren A; Schoub BD; Tobler LH; Hogrefe W; du P Heyns A; Stramer SL; Crookes RL
    Transfusion; 2008 Feb; 48(2):295-303. PubMed ID: 18005322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.
    Celum C; Wald A; Lingappa JR; Magaret AS; Wang RS; Mugo N; Mujugira A; Baeten JM; Mullins JI; Hughes JP; Bukusi EA; Cohen CR; Katabira E; Ronald A; Kiarie J; Farquhar C; Stewart GJ; Makhema J; Essex M; Were E; Fife KH; de Bruyn G; Gray GE; McIntyre JA; Manongi R; Kapiga S; Coetzee D; Allen S; Inambao M; Kayitenkore K; Karita E; Kanweka W; Delany S; Rees H; Vwalika B; Stevens W; Campbell MS; Thomas KK; Coombs RW; Morrow R; Whittington WL; McElrath MJ; Barnes L; Ridzon R; Corey L;
    N Engl J Med; 2010 Feb; 362(5):427-39. PubMed ID: 20089951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials.
    Johnston C; Saracino M; Kuntz S; Magaret A; Selke S; Huang ML; Schiffer JT; Koelle DM; Corey L; Wald A
    Lancet; 2012 Feb; 379(9816):641-7. PubMed ID: 22225814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient Increase in Herpes Simplex Virus Type 2 (HSV-2)-Associated Genital Ulcers Following Initiation of Antiretroviral Therapy in HIV/HSV-2-Coinfected Individuals.
    Fife KH; Mugwanya K; Thomas KK; Baeten JM; Celum C; Bukusi E; de Bruyn G; Mujugira A; Vwalika B; Wald A; Lingappa JR;
    J Infect Dis; 2016 May; 213(10):1573-8. PubMed ID: 26704611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.
    Lingappa JR; Baeten JM; Wald A; Hughes JP; Thomas KK; Mujugira A; Mugo N; Bukusi EA; Cohen CR; Katabira E; Ronald A; Kiarie J; Farquhar C; Stewart GJ; Makhema J; Essex M; Were E; Fife KH; de Bruyn G; Gray GE; McIntyre JA; Manongi R; Kapiga S; Coetzee D; Allen S; Inambao M; Kayitenkore K; Karita E; Kanweka W; Delany S; Rees H; Vwalika B; Magaret AS; Wang RS; Kidoguchi L; Barnes L; Ridzon R; Corey L; Celum C;
    Lancet; 2010 Mar; 375(9717):824-33. PubMed ID: 20153888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daily acyclovir to decrease herpes simplex virus type 2 (HSV-2) transmission from HSV-2/HIV-1 coinfected persons: a randomized controlled trial.
    Mujugira A; Magaret AS; Celum C; Baeten JM; Lingappa JR; Morrow RA; Fife KH; Delany-Moretlwe S; de Bruyn G; Bukusi EA; Karita E; Kapiga S; Corey L; Wald A;
    J Infect Dis; 2013 Nov; 208(9):1366-74. PubMed ID: 23901094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-daily valacyclovir to reduce the risk of transmission of genital herpes.
    Corey L; Wald A; Patel R; Sacks SL; Tyring SK; Warren T; Douglas JM; Paavonen J; Morrow RA; Beutner KR; Stratchounsky LS; Mertz G; Keene ON; Watson HA; Tait D; Vargas-Cortes M;
    N Engl J Med; 2004 Jan; 350(1):11-20. PubMed ID: 14702423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of herpes simplex virus testing and treatment strategies in febrile neonates.
    Caviness AC; Demmler GJ; Swint JM; Cantor SB
    Arch Pediatr Adolesc Med; 2008 Jul; 162(7):665-74. PubMed ID: 18606938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.